Patents by Inventor Angelo Facchiano

Angelo Facchiano has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptide inhibiting platelet derived growth factor (PDGF-BB) and fibroblast growth factor (bFGF) activity
    Patent number: 7009036
    Abstract: A novel peptide, derived from the human fibroblast growth factor (bFGF), is identified. The molecule is able to inhibit in vitro the effects of Platelet Derived Growth Factor (PDGF-BB) and basic Fibroblast Growth Factor (bFGF) on primary rat smooth muscle cells (RASMC) and primary bovine endothelial cells (BAEC) The molecule is also able to inhibit in vivo angiogenesis CD1 mice.
    Type: Grant
    Filed: February 20, 2002
    Date of Patent: March 7, 2006
    Assignee: Provincia Italiana Della Congregazione Dei Figli Dell'Immacolata Concezione—Instituto Dermopatico Dell'Immacolata
    Inventors: Antonio Facchiano, Francesco Facchiano, Angelo Facchiano
  • Peptide inhibiting platelet derived growth factor (PDGF-BB) and fibroblast growth factor (bFGF) activity
    Publication number: 20060014693
    Abstract: A novel peptide, derived from the human fibroblast growth factor (bFGF), is identified. Said molecule is able to inhibit in vitro the effects of Platelet Derived Growth Factor (PDGF-BB) and basic Fibroblast Growth Factor (bFGF) on primary rat smooth muscle cells (RASMC) and primary bovine endothelial cells (BAEC). Said molecule is also able to inhibit in vivo angiogenesis CD1 mice.
    Type: Application
    Filed: June 29, 2005
    Publication date: January 19, 2006
    Applicants: DELL' IMMACOLATA CONCEZIONE-ISTITUTO DERMOOPATICO DELL' IMMACOLATA
    Inventors: Antonio Facchiano, Francesco Facchiano, Angelo Facchiano
  • Peptide inhibiting platelet derived growth factor (PDGF-BB) and fibroblast growth factor (bFGF) activity
    Publication number: 20020119931
    Abstract: A novel peptide, derived from the human fibroblast growth factor (bFGF), is identified. The molecule is able to inhibit in vitro the effects of Platelet Derived Growth Factor (PDGF-BB) and basic Fibroblast Growth Factor (bFGF) on primary rat smooth muscle cells (RASMC) and primary bovine endothelial cells (BAEC) The molecule is also able to inhibit in vivo angiogenesis CD1 mice.
    Type: Application
    Filed: February 20, 2002
    Publication date: August 29, 2002
    Inventors: Antonio Facchiano, Francesco Facchiano, Angelo Facchiano